Dow Jones

40 211,72

0,00%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Allos Therapeutics, Inc. (MM) (ALTH)
Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ALTH

1 2 3 4 5 6 7 8 9 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
16/04/2012	22h59	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
16/04/2012	14h15	Business Wire	Spectrum Pharmaceuticals Commences Tender Offer for All Outstanding Shares of Allos Therapeutics	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
16/04/2012	12h04	Edgar (US Regulatory)	Statement of Ownership: Solicitation (SC 14D9)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
16/04/2012	12h04	Edgar (US Regulatory)	Tender offer statement by Third Party (SC TO-T)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
13/04/2012	23h24	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
13/04/2012	23h11	Edgar (US Regulatory)	Amended Annual Statement of Changes in Beneficial Ownership (5/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
09/04/2012	17h26	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
09/04/2012	14h15	Zacks	Allos Eyed by Spectrum Pharma - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
09/04/2012	11h06	Zacks	Company News for April 9, 2012 - Corporate Summary	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/04/2012	12h07	Edgar (US Regulatory)	Written communication by the subject company relating to a third party tender offer (SC14D9C)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/04/2012	12h06	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/04/2012	23h23	Edgar (US Regulatory)	Written communication relating to an issuer or third party (SC TO-C)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/04/2012	20h07	Dow Jones News	UPDATE: Amid Setback, Spectrum Pharma To Buy Allos For $206 Million	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/04/2012	16h28	PR Newswire (US)	Allos Therapeutics, Inc. (ALTH) Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition By Spectrum ...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/04/2012	14h52	PR Newswire (US)	Block & Leviton LLP Investigates Allos Therapeutics, Inc. for Possible Breaches of Fiduciary Duties for Its Proposed Merger w...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/04/2012	13h00	Business Wire	Spectrum Pharmaceuticals to Acquire Allos Therapeutics: Acquisition Expected to Be Accretive on a Cash Basis in Q4 of 2012	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
30/03/2012	10h14	Zacks	Zacks #1 Rank Additions for Friday - Tale of the Tape	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
26/03/2012	12h03	Edgar (US Regulatory)	Amended Quarterly Report (10-Q/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
22/03/2012	11h00	Zacks	Allos Upped to Outperform - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/03/2012	09h15	Zacks	Allos Narrows Loss - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/03/2012	22h00	Business Wire	Allos Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
02/03/2012	00h18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
27/02/2012	23h48	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
24/02/2012	00h19	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
21/02/2012	14h00	Business Wire	Allos Therapeutics to Report Fourth Quarter and Full Year 2011 Results on March 6, 2012	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
14/02/2012	21h33	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
14/02/2012	16h43	Edgar (US Regulatory)	Schedule 13G	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
10/02/2012	16h59	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/02/2012	18h46	Zacks	ALTH Seeks Review of Folotyn Verdict - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
30/01/2012	14h30	Business Wire	Allos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at the European Medicines Agency	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)